Literature DB >> 7939912

Safe administration of iron dextran to a patient who reacted to the test dose.

M S Monaghan1, G Glasco, G St John, R W Bradsher, K M Olsen.   

Abstract

Parenteral iron therapy is infrequently required but generally well tolerated. We present a case in which intravenous iron dextran was successfully given to a patient who had an anaphylactoid reaction to the test dose. After pretreatment with methylprednisolone, diphenhydramine, ephedrine, and dextran 1, 2 g of iron dextran were safely given over several days; pretreatment was administered only on day 1. In the rare cases in which an anaphylactic agent must be given to a patient with a history of a life-threatening reaction to the agent, pretreatment along with slow escalation of dose may allow safe administration of the offending drug.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7939912     DOI: 10.1097/00007611-199410000-00011

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

Review 1.  Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management.

Authors:  J Szebeni; S Fishbane; M Hedenus; S Howaldt; F Locatelli; S Patni; D Rampton; G Weiss; J Folkersen
Journal:  Br J Pharmacol       Date:  2015-10-25       Impact factor: 8.739

Review 2.  Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults.

Authors:  Wendy Lim; Waqqas Afif; Sandra Knowles; Gloria Lim; Yulia Lin; Charmaine Mothersill; Irina Nistor; Faisal Rehman; Christine Song; Ted Xenodemetropoulos
Journal:  Vox Sang       Date:  2019-04-02       Impact factor: 2.144

3.  Two case reports of desensitization in patients with hypersensitivity to iron.

Authors:  Edgardo Chapman; Drixie Leal; Leidy Alvarez; Mónica Duarte; Elizabeth García
Journal:  World Allergy Organ J       Date:  2017-10-10       Impact factor: 4.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.